68893-82-3 Usage
Indications
Human rPTH (1-34) has been produced by recombinant
technologies, is now approved, and will soon be available
for the treatment of osteoporosis. It is given subcutaneously,
25 μg/day cyclically for 12 to 18 months, to increase
bone density in individuals with a history of fractures,
severe osteopenia, or osteoporosis. PTHrP (1-36)
has also been synthesized and is in early clinical trials.
Check Digit Verification of cas no
The CAS Registry Mumber 68893-82-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,8,9 and 3 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 68893-82:
(7*6)+(6*8)+(5*8)+(4*9)+(3*3)+(2*8)+(1*2)=193
193 % 10 = 3
So 68893-82-3 is a valid CAS Registry Number.